EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Complete Healing After Umbilical Mesenchymal Stem Cell-Derived Exosome Therapy For a Refractory Complex Anal Fistula

N Cigdem Arslan, Ilknur Erenler, Erdal Karaoz

Cureus · 26.02.2026

DOI: 10.7759/cureus.104324 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 26.02.2026. Verfasst von N Cigdem Arslan und 2 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Istanbul Health and Technology University, Istanbul, TUR. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complex anal fistulas pose a persistent challenge due to high recurrence and the risk of continence impairment. While sphincter-sparing techniques exist, outcomes are variable in refractory disease. Mesenchymal stromal cell (MSC) therapies show promise but face logistical barriers, prompting interest in acellular exosome-based approaches. We report a 45-year-old woman with a complex anterior anal fistula refractory to multiple surgeries, including two endoanal advancement flaps, complicated by new-onset flatus incontinence. Following the second endoanal advancement flap, the patient's Cleveland Clinic Continence Score (CCIS) was 10, and the Quality of Life in Patients with Anal Fistula Questionnaire (QoLAF-Q) score was 51. A two-stage salvage strategy was undertaken: meticulous curettage and closure of the internal opening, followed by local administration of MSC-derived exosomes at baseline and three weeks. Significant wound reduction was observed, progressing to complete epithelialization within two weeks after the second exosome application. At six months after combined surgical intervention and exosome therapy, CCIS and QoLAF-Q scores improved to 0 and 28, respectively, indicating full restoration of continence and a marked improvement in quality of life. This case suggests that local exosome therapy, used as an adjunct to careful surgical preparation, may support healing and functional recovery in refractory complex anal fistulas. Controlled studies with standardized protocols are warranted to define efficacy, dosing, and durability.

Schlagwörter

Stichwörter der Autor:innen

anal fistulacomplex woundexosome therapyrecurrent fistulastem cell

Autor:innen und Institutionen

  • General Surgery, Istanbul Health and Technology University, Istanbul, TUR.
  • General and Colorectal Surgery, Private Clinic, Istanbul, TUR.
  • Histology and Embryology, IIstinye University, Istanbul, TUR.
  • Center for Regenerative Medicine and Stem Cell Research and Manufacturing (LivMedCell), Liv Hospital Ulus, Istanbul, TUR.

Zitieren

APA

Arslan, N. C., Erenler, I., & Karaoz, E. (2026). Complete Healing After Umbilical Mesenchymal Stem Cell-Derived Exosome Therapy For a Refractory Complex Anal Fistula. Cureus. https://doi.org/10.7759/cureus.104324

Vancouver

Arslan NC, Erenler I, Karaoz E. Complete Healing After Umbilical Mesenchymal Stem Cell-Derived Exosome Therapy For a Refractory Complex Anal Fistula. Cureus. 2026. doi:10.7759/cureus.104324

BibTeX
@article{Arslan2026,
  author = {Arslan, N Cigdem and Erenler, Ilknur and Karaoz, Erdal},
  title = {Complete Healing After Umbilical Mesenchymal Stem Cell-Derived Exosome Therapy For a Refractory Complex Anal Fistula},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.104324}
}
Kostenlos starten →